Indeed Wayne.
I've posted on this previously, but for those that don't know, re biomarkers refer to page 26 below...
http://www.neurenpharma.com/ssl/cms/files_cms/NEU%20Arrowhead%20TBI%20Conference%20March%202012.pdf
And this old announcement here...
http://www.neurenpharma.com/ssl/cms/files_cms/NEU%20NNZ-2566%20first%20cohorts%20200907.pdf
Then head on over to Banyan's website and have a read of the work being conducted on their Biomarkers and then re-read the outline of the 2014 TBI Conference where Dr. Stefania Mondello will be presenting initial findings from the Phase II INTREPID Trial (first cohort) on Day One at 1.25pm.
Note, she is also one of the speakers featured at this event.
Very interesting.
Tony
intrepid2566, page-15
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.176B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.05 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |